Orleans Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Orleans Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,246	Closed	-$415K	–	109
2025 Q1	$415K	Buy	3,246 +44	+1%	+$5.97K	0.24%	70
2024 Q4	$430K	Sell	3,202 -50	-2%	-$7.03K	0.24%	71
2024 Q3	$473K	Buy	3,252 +235	+8%	+$34K	0.27%	65
2024 Q2	$414K	Buy	3,017 +62	+2%	+$8.28K	0.26%	60
2024 Q1	$405K	Buy	+2,955	New	+$404K	0.27%	59
2023 Q4	–	Sell	-2,515	Closed	-$308K	–	82
2023 Q3	$308K	Buy	+2,515	New	+$320K	0.23%	62
2022 Q1	–	Sell	-4,960	Closed	-$757K	–	86
2021 Q4	$757K	Sell	4,960 -1,015	-17%	-$157K	0.43%	47
2021 Q3	$966K	Buy	+5,975	New	+$1.01M	0.62%	45
2018 Q1	–	Sell	-5,085	Closed	-$543K	–	83
2017 Q4	$543K	Hold	5,085	–	–	0.39%	64
2017 Q3	$565K	Buy	5,085 +600	+13%	+$64.1K	0.42%	57
2017 Q2	$464K	Hold	4,485	–	–	0.33%	65
2017 Q1	$438K	Buy	4,485 +1,500	+50%	+$144K	0.31%	67
2016 Q4	$264K	Buy	+2,985	New	+$272K	0.19%	77

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Orleans Capital Management's IBB Position: Q2 2025 in Review

Orleans Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 3,246 shares — an estimated $415K sold.

Orleans Capital Management first reported a position in IBB in Q4 2016 and held it in 13 quarters. The position peaked at $966K in Q3 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

Orleans Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
Orleans Capital Management sold 3,246 iShares Biotechnology ETF shares in Q2 2025, an estimated $415K.
Orleans Capital Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 13 quarters.
Orleans Capital Management's iShares Biotechnology ETF position peaked at $966K in Q3 2021.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Orleans Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.